CNBC Television published this video item, entitled “South Africa suspends use of Oxford-AstraZeneca vaccine due to ineffectiveness” – below is their description.
Meg Tirrell reports the Oxford-AstraZeneca vaccine is only 22 percent effective against the South African Covid variant. There have yet to be clinical trials to see how effective Pfizer and Moderna are against Covid variants. She joins Shep Smith to report.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.